Physician profile
James C Matchison
NPI 1629275631
$33,339.91
in general payments reported to CMS, 2019-2025
35 companies · $2,340 in 2025
The $2,340 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $5,379 · 2021: $1,819 · 2022: $3,788 · 2023: $2,979 · 2024: $5,742 · 2025: $2,340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,054 · Honoraria: $2,750 · Travel and Lodging: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,053.66 |
| Honoraria | $2,750.00 |
| Travel and Lodging | $257.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $16,447.89 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $7,268.29 | 2019-2025 | Impella |
| Boston Scientific Corporation | $2,413.06 | 2019-2025 | Avvigo Guidance System, General - Balloon Catheters, Crossboss |
| Shockwave Medical, INC | $1,645.99 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $918.99 | 2019-2023 | |
| Medtronic, INC. | $582.95 | 2021-2023 | Linq II, Micra, Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $497.46 | 2019-2025 | |
| Abbott Laboratories | $472.98 | 2020-2025 | Xience Skypoint, Dragonfly Opstar, Navitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $419.65 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $414.62 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $376.60 | 2019-2024 | Xarelto |
| Pfizer INC. | $371.62 | 2019-2025 | |
| Medtronic Vascular, INC. | $276.98 | 2019-2020 | |
| Livanova USA, INC. | $191.80 | 2022 | |
| Astellas Pharma US INC | $112.89 | 2020-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $112.85 | 2019-2025 | Repatha, Repatha |
| Cardiva Medical, INC. | $109.11 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Savvywire |
| Terumo Medical Corporation | $99.05 | 2022 | |
| Teleflex LLC | $84.72 | 2019-2024 | Guideliner |
| Kestra Medical Technology Services, INC. | $63.88 | 2023-2025 | Assure Wcd |
| Novo Nordisk INC | $57.26 | 2021-2022 | |
| Scpharmaceuticals INC. | $49.76 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $49.68 | 2019-2023 | Farxiga |
| Regeneron Healthcare Solutions, INC. | $34.99 | 2019 | |
| Sanofi-Aventis U.S. LLC | $31.28 | 2019 | |
| Ionis Pharmaceuticals, INC. | $30.66 | 2025 | Tryngolza |
| Bridgebio Pharma, INC. | $30.32 | 2025 | Attruby |
| Glaxosmithkline, LLC. | $29.12 | 2025 | Shingrix, Arexvy |
| Inspire Medical Systems, INC. | $26.83 | 2025 | Inspire |
| Acist Medical Systems, INC. | $23.00 | 2021 | |
| Merck Sharp & Dohme LLC | $21.93 | 2023 | Verquvo |
| Cardiovascular Systems INC. | $20.00 | 2023 | Diamondback Coronary |
| Actelion Pharmaceuticals US, INC. | $19.83 | 2019 | |
| Chiesi USA, INC. | $17.41 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.46 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Matchison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.